A test that measures kappa immunoglobulin free light chains in cerebrospinal fluid (KCSF) is a valid option for diagnosing multiple sclerosis (MS), new research suggests. Results showed that compared ...

Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise ...

A new MS blood test from Roche has received EU approval and may help track disease activity by measuring nerve damage linked ...

Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other neurodegenerative ...

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...

Please provide your email address to receive an email when new articles are posted on . MSDA Test disease activity scores range from 1 (low) to 10 (high). Areas under the curve included 0.81 for Gd+ ...

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...

Add Yahoo as a preferred source to see more of our stories on Google. A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.